MAURICE ALISSE: Open Payments
NPI 1730130386 · NEWBURGH, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,607 in 111 payments from 25 companies in 2025. Trend: 2023 $3,434 · 2024 $3,058 · 2025 $2,607
Food & beverage: $2,607
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $570 |
| Lilly USA, LLC | 14 | $241 |
| PFIZER INC. | 11 | $209 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $176 |
| Amgen Inc. | 10 | $162 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $141 |
| Otsuka America Pharmaceutical, Inc. | 6 | $136 |
| Axsome Therapeutics, Inc. | 5 | $125 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $125 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $114 |
Products named: JARDIANCE, TEZSPIRE, REXULTI, OTEZLA, TRINTELLIX, AIRSUPRA, Auvelity, CAPLYTA.
Industry payments across NY — which companies pay providers there.
